2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$1.93-$0.01 (-0.77%)
Price as of Sep 11, 2026 7:30 PM EDT- $351.3MMarket Cap
- 287.38%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$1.93-$0.01 (-0.77%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.94 | ||
Change | $0.00 (0.00%) | ||
Open | $1.98 | ||
High | $2.00 | ||
Low | $1.89 | ||
Previous Close | $1.94 | ||
Volume | 465,714 | ||
30-Day Average Volume | 415,698 | ||
1-Week Change | -8.06% | ||
1-Month Change | -5.83% | ||
1-Year Change | 287.38% | ||
3-Year Change | -17.80% | ||
5-Year Change | -92.81% | ||
Fundamentals | |||
Shares Outstanding | 181.1M | ||
Total Assets | $287.0M | ||
Market Cap | $351.3M | ||
Enterprise Value | $301.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$20.5M | ||
EBIT | -$34.5M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $109.7M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue